|
|
At the U.S. Food and Drug Administration, transparency with our stakeholders is essential to our mission. Patients, healthcare providers, and industry rely on a regulatory system that is rigorous, but also predictable, understandable, and accountable.
As part of the FDA’s broader transparency efforts, we are taking steps to modernize how we communicate, how we make decisions, and how we carry out regulatory responsibilities. A critical component of that effort is the transformation of our inspectional enterprise, including how we plan, coordinate, and execute inspections across the agency.
We are advancing that transformation through a more aligned, risk-informed, and transparent approach to inspectional operations that is already taking shape across the FDA.
|
|
|
|
